全球先进治疗药物市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，先进疗法市场规模将从 2025 年的 672.1 亿美元成长至 2,710.6 亿美元，2026 年至 2034 年的复合年增长率为 16.76%。

受基因疗法和细胞疗法突破性进展的推动，全球先进治疗药物（ATMP）市场正经历快速成长。先进治疗药物（ATMP）包括基因疗法、细胞疗法和组织工程产品。人们对罕见疾病和遗传疾病治疗日益增长的关注也推动了这一市场扩张。

关键成长要素包括对生物技术研究投入的增加和有利的法规结构。製药公司正在加速推动创新治疗方法的临床试验。个人化医疗方法的日益普及进一步刺激了需求。此外，生物技术公司与研究机构之间日益密切的合作也正在推动创新。

随着更多先进治疗药物（ATMP）获得监管部门核准并实现商业化，市场前景仍然强劲。新兴市场正透过投资先进的医疗基础设施创造成长机会。各公司正致力于可扩展的生产和成本优化。随着再生医学的进步，全球先进治疗药物市场预计将持续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球先进治疗药物市场：依治疗方法

• 市场分析、洞察与预测
• 细胞疗法
• 基因治疗
• 组织工程

第五章 全球先进治疗药物市场：依适应症划分

• 市场分析、洞察与预测
• 肿瘤学
• 神经病学
• 心臟病学
• 皮肤科
• 感染疾病
• 肌肉骨骼疾病
• 整形外科
• 其他（遗传性疾病等）

第六章 全球先进治疗药物市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 专科诊所
• 其他（研究机构等）

第七章 全球先进治疗药物市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Spark Therapeutics Inc
  • Bluebird Bio Inc
  • Novartis AG
  • UniQure NV
  • Medipost
  • Vericel Corporation
  • Pharmicell Co. Ltd
  • Organogenesis Inc

The Advanced Therapy Medicinal Products Market size is expected to reach USD 271.06 Billion in 2034 from USD 67.21 Billion (2025) growing at a CAGR of 16.76% during 2026-2034.

The Global Advanced Therapy Medicinal Products Market is experiencing rapid growth driven by breakthroughs in gene and cell therapies. Advanced therapy medicinal products (ATMPs) include gene therapy, cell therapy, and tissue-engineered products. Increasing focus on treating rare and genetic diseases is supporting market expansion.

Major growth drivers include rising investment in biotechnology research and supportive regulatory frameworks. Pharmaceutical companies are accelerating clinical trials for innovative therapies. Growing adoption of personalized medicine approaches is further strengthening demand. Additionally, expanding collaborations between biotech firms and research institutions are fueling innovation.

Future prospects remain strong as more ATMPs receive regulatory approval and commercialization. Emerging markets investing in advanced healthcare infrastructure will create growth opportunities. Companies are focusing on scalable manufacturing and cost optimization. As regenerative medicine advances, the Global Advanced Therapy Medicinal Products Market is expected to witness sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy Type

• Cell Therapy
• Gene Therapy
• Tissue Engineering

By Indication

• Oncology
• Neurology
• Cardiology
• Dermatology
• Infectious Diseases
• Musculoskeletal Disorders
• Orthopedics
• Others (Genetic Disorders, etc.)

By End-user

• Hospitals
• Specialty Clinics
• Others (Research Institutes, etc.)

COMPANIES PROFILED

• Spark Therapeutics Inc, Bluebird Bio Inc, Novartis AG, UniQure NV, Medipost, Vericel Corporation, Pharmicell Co Ltd, Organogenesis Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY THERAPY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapy Type
• 4.2. Cell Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Tissue Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Musculoskeletal Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Orthopedics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others (Genetic Disorders, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others (Research Institutes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Therapy Type
  • 7.2.2 By Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Therapy Type
  • 7.3.2 By Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Therapy Type
  • 7.4.2 By Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Therapy Type
  • 7.5.2 By Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Therapy Type
  • 7.6.2 By Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Spark Therapeutics Inc
  • 9.2.2 Bluebird Bio Inc
  • 9.2.3 Novartis AG
  • 9.2.4 UniQure N.V
  • 9.2.5 Medipost
  • 9.2.6 Vericel Corporation
  • 9.2.7 Pharmicell Co. Ltd
  • 9.2.8 Organogenesis Inc